An observational study in Elderly Care, sponsored by University Hospital, Angers. Completed at 1 site in France. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2017-05-12.
Sponsored by University Hospital, Angers · Observational
Elderly patients are increasingly admitted in the Intensive Care Unit. Short-term outcome (e.g. hospital survival) of an ICU stay is improving in this population but little data have been published on long-term outcome. Beyond survival, outcome assessment in the elderly requires to evaluate several aspects of health: mental status, activity of daily living, pain, depression, frailty... referred by geriatrician as "comprehensive geriatric assessment' (CGA).
The purpose of the SENIOREA study is to evaluate one year outcome of elderly patients mechanically ventilated in the ICU by performing CGA one year after ICU admission. CGA will be performed on the patients' site of living.
This prospective multicentric trial will be conducted over 8 medico-surgical ICUs.
University Hospital, Angers is the lead sponsor of 464 studies on the registry; 116 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients aged 75 and over admitted in one of the participating ICU and requiring mechanical ventilation will be recruited for this study
Exclusion Criteria:
One year outcome
Survival and health status will be assessed using comprehensive geriatric assessment (CGA)
Time frame: 1 year
Predictors of one-year outcome
The secondary assessment criteria as predictors of one year outcome will be researched among: * CGA on ICU entry (based on family interview) * Vitamin D blood concentration on ICU entry * SOFA and SAPSII score on ICU entry * Duration of organ dysfunction (ventilator support, renal replacement therapy, vasopressor) * ICU length of stay
Time frame: one year
This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Angers